194 related articles for article (PubMed ID: 18433608)
1. Beyond the guidelines in the treatment of peripheral T-cell lymphoma: new drug development.
Chen AI; Advani RH
J Natl Compr Canc Netw; 2008 Apr; 6(4):428-35. PubMed ID: 18433608
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
Coiffier B; Federico M; Caballero D; Dearden C; Morschhauser F; Jäger U; Trümper L; Zucca E; Gomes da Silva M; Pettengell R; Weidmann E; d'Amore F; Tilly H; Zinzani PL
Cancer Treat Rev; 2014 Oct; 40(9):1080-8. PubMed ID: 25199959
[TBL] [Abstract][Full Text] [Related]
3. Novel therapies in peripheral T-cell lymphomas.
O'Leary HM; Savage KJ
Curr Oncol Rep; 2008 Sep; 10(5):404-11. PubMed ID: 18706268
[TBL] [Abstract][Full Text] [Related]
4. Systemic monotherapy vs combination therapy for CTCL: rationale and future strategies.
Duvic M
Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):33-40. PubMed ID: 17474358
[TBL] [Abstract][Full Text] [Related]
5. Novel agents in development for peripheral T-cell lymphoma.
O'Connor OA
Semin Hematol; 2010 Apr; 47 Suppl 1():S11-4. PubMed ID: 20359580
[TBL] [Abstract][Full Text] [Related]
6. Peripheral T-cell lymphoma.
Foss FM; Zinzani PL; Vose JM; Gascoyne RD; Rosen ST; Tobinai K
Blood; 2011 Jun; 117(25):6756-67. PubMed ID: 21493798
[TBL] [Abstract][Full Text] [Related]
7. Development of new agents for peripheral T-cell lymphoma.
Ito Y; Makita S; Tobinai K
Expert Opin Biol Ther; 2019 Mar; 19(3):197-209. PubMed ID: 30658046
[TBL] [Abstract][Full Text] [Related]
8. Management of advanced-stage peripheral T-cell lymphomas.
Kimby E
Curr Hematol Malig Rep; 2007 Oct; 2(4):242-8. PubMed ID: 20425376
[TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory peripheral T-cell lymphoma with denileukin diftitox (ONTAK).
Talpur R; Apisarnthanarax N; Ward S; Duvic M
Leuk Lymphoma; 2002 Jan; 43(1):121-6. PubMed ID: 11908715
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
Rogers AM; Brammer JE
Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515
[TBL] [Abstract][Full Text] [Related]
11. [Current development of new drugs in malignant lymphoma].
Ogura M
Nihon Rinsho; 2012 Apr; 70 Suppl 2():715-30. PubMed ID: 23134034
[No Abstract] [Full Text] [Related]
12. T time: Emerging and new therapies for peripheral T-cell lymphoma.
Mina A; Pro B
Blood Rev; 2022 Mar; 52():100889. PubMed ID: 34716031
[TBL] [Abstract][Full Text] [Related]
13. New drug therapies in peripheral T-cell lymphoma.
Howman RA; Prince HM
Expert Rev Anticancer Ther; 2011 Mar; 11(3):457-72. PubMed ID: 21417858
[TBL] [Abstract][Full Text] [Related]
14. Novel therapies in peripheral T-cell lymphomas.
O'Leary HM; Savage KJ
Curr Hematol Malig Rep; 2008 Oct; 3(4):213-20. PubMed ID: 20425468
[TBL] [Abstract][Full Text] [Related]
15. PTCL therapies: a review of treatment and outline of novel therapies.
Khan N; Cheson BD
Am J Ther; 2013; 20(5):524-33. PubMed ID: 23528371
[TBL] [Abstract][Full Text] [Related]
16. Current management of peripheral T-cell lymphomas.
Gooptu M; Rhoades R; Pro B
Cancer Treat Res; 2015; 165():289-303. PubMed ID: 25655615
[TBL] [Abstract][Full Text] [Related]
17. New directions in treating peripheral T-cell lymphomas (PTCL): leveraging epigenetic modifiers alone and in combination.
Ma H; O'Connor OA; Marchi E
Expert Rev Hematol; 2019 Mar; 12(3):137-146. PubMed ID: 30782038
[TBL] [Abstract][Full Text] [Related]
18. Novel targeted therapies in peripheral T cell lymphoma.
Jagadeesh D; Smith MR
Discov Med; 2013 Jun; 15(85):367-78. PubMed ID: 23819951
[TBL] [Abstract][Full Text] [Related]
19. De novo maintenance therapy with denileukin diftitox (Ontak) in a patient with peripheral T-cell lymphoma is associated with prolonged remission.
Wong BY; Ma Y; Fitzwilson R; Dang NH
Am J Hematol; 2008 Jul; 83(7):596-8. PubMed ID: 18383317
[TBL] [Abstract][Full Text] [Related]
20. Romidepsin for the Treatment of Peripheral T-Cell Lymphoma.
Iyer SP; Foss FF
Oncologist; 2015 Sep; 20(9):1084-91. PubMed ID: 26099743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
